Hyderabad: The ₹250-crore expansion plan of Aurobindo Pharma's manufacturing facility in Srikakulam district of Andhra Pradesh has been accorded environmental clearance by the the Ministry of Environment, Forests and Climate Change.
The plan for increasing the production capacity of for bulk drugs and intermediates manufacturing unit from 583.31 TPM (tonnes per month) to 1518.3 TPM was approved by an expert appraisal committee of the Ministry at a meeting on 8 April.
According to the minutes of the meeting, the project also involves installation of a captive power plant of 8.85 MW.
The project is expected to create jobs for 600 people directly and 120 indirectly.
The estimated cost for expansion is ₹250 crore.
The total capital cost earmarked for environmental pollution control measures is ₹32.77 crore and the recurring cost (operations and maintenance) would be about ₹8.84 crore per annum.